 |
|
|
|
|
 |
Last Updated: Apr 18, 2011 - 2:22:02 PM |
Latest Research
U of M scientist gets 5-year, $10 million grant to direct innovative HIV research program
Reuben Harris, professor in the University of Minnesota's College of Biological Sciences, has been awarded a five-year, $10 million grant from the National Institutes of Health to direct a large-scale research effort to study a human antiviral protein with potential for treating HIV and other viral diseases.
Apr 18, 2011 - 4:00:00 AM
|
Latest Research
New drug regimens cut HIV spread from mother to infant
Pregnant women who are unaware that they have HIV miss the chance for drug treatment that can benefit not only their own health, but could also prevent them from transmitting the virus to their infants. When HIV is not diagnosed until women go into labor, their infants are usually treated soon after birth with the anti HIV drug zidovudine (ZDV), to prevent the infants from becoming infected with the virus.
Mar 2, 2011 - 5:00:00 AM
|
Latest Research
6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds
Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.
Mar 2, 2011 - 5:00:00 AM
|
Latest Research
New vaccine technology protects mice from hepatitis C virus
Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark. Since the virus mutates strongly, we have no traditional vaccine, but researchers at the University of Copenhagen are now the first to succeed in developing a vaccine, which provides future hope for medical protection from this type of hepatitis.
Feb 23, 2011 - 5:00:00 AM
|
Latest Research
Study suggests why HIV-uninfected babies of mothers with HIV might be more prone to infections
Babies whose mothers have HIV, but who are not HIV-infected themselves, are born with lower levels of specific proteins in their blood called antibodies, which fight infection, compared with babies not exposed to HIV, a new study has found. The finding, published today in the Journal of the American Medical Association, might explain in part why uninfected babies born to women with HIV have a higher risk of illness and death early in life.
Feb 8, 2011 - 5:00:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Broadly-reactive neutralizing antibodies bring scientists closer to HIV vaccine
Researchers from Seattle Biomedical Research Institute (Seattle BioMed), Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
Jan 13, 2011 - 6:42:29 PM
|
Latest Research
Fulbright Award has UC educator examining health challenges in China
The New Year has a University of Cincinnati professor sharing his vast and vital research background on health education in a new location. Randall Cottrell, a UC professor of health promotion and education in the College of Education, Criminal Justice, and Human Services (CECH), is spending the winter and spring academic quarters at Zhejiang University in Hangzhou, China. He says he is one of only two public health educators nationally to receive a Fulbright Scholar Award to explore health education efforts in China and share research about health education programs in the United States.
Jan 4, 2011 - 5:00:00 AM
|
Latest Research
Surprising AIDS-treatment benefits, prevention strategy in epidemic regions of Africa
Two teams of researchers at UC San Diego and other U.S. and African universities and the World Bank have documented significant spillover benefits of a drug therapy to combat AIDS symptoms and a novel prevention strategy that focuses on girls in Sub-Saharan Africa, an area with two-thirds of the world's HIV infections.
Dec 1, 2010 - 5:00:00 AM
|
Latest Research
30 years on in the epicenter of the African AIDS epidemic
The impact of 30 years of HIV on an area once described as the epicentre of the African AIDS epidemic will be discussed at a lecture hosted by the University of East Anglia (UEA) in London this month.
Nov 12, 2010 - 5:00:00 AM
|
Latest Research
HHS agencies partner with PEPFAR to transform African medical education
The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with a plan to invest $130 million over five years to transform African medical education and dramatically increase the number of health care workers.
Oct 7, 2010 - 4:00:00 AM
|
Latest Research
Doctors at University of Colorado School of Medicine to train African doctors in AIDS care
The HIV epidemic continues to grow, especially in Africa where it has orphaned millions of children and decimated entire communities. In this environment, funding to train African health care providers is critical.
Oct 7, 2010 - 4:00:00 AM
|
Latest Research
Unprecedented effort to seek, test and treat inmates with HIV
Twelve scientific teams in more than a dozen states will receive National Institutes of Health (NIH) grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system. The grants, announced today, will be awarded primarily by the National Institute on Drug Abuse (NIDA), with additional support from the National Institute of Mental Health (NIMH) and the National Institute of Allergy and Infectious Diseases (NIAID), all components of NIH. The research will take place over a five-year period.
Sep 23, 2010 - 4:00:00 AM
|
Latest Research
Vitamin A increases the presence of the HIV virus in breast milk
ANN ARBOR, Mich.---Vitamin A and beta-carotene supplements are unsafe for HIV-positive women who breastfeed because they may boost the excretion of HIV in breast milk---thereby increasing the chances of transmitting the infection to the child, a pair of new studies suggest.
Aug 26, 2010 - 4:00:00 AM
|
Latest Research
UofL receives $3.15 million grant from Helmsley Charitable Trust
The University of Louisville has received a $3.15 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to support the UofL James Graham Brown Cancer Center and cancer research taking place in Owensboro. The grant will be matched with state Bucks for Brains funding to bring more than $4.5 million to the Owensboro Cancer Research Program (OCRP).
Aug 5, 2010 - 4:00:00 AM
|
Latest Research
NIH-funded study finds early HAART during TB treatment boosts survival rate in co-infected people
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on AIDS and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented today at the XVIII International AIDS Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne E. Goldfeld, M.D., and Sok Thim, M.D.
Jul 22, 2010 - 4:00:00 AM
|
Latest Research
New global report launched by the International AIDS Society recommends a new paradigm for treating injecting drug users: 'Seek, test, treat and retain'
Thursday, 22 July, 2010 (Vienna, Austria)-- Against the backdrop of some of the globe's fastest growing HIV epidemics in Eastern Europe and Central Asia, a report launched today at the XVIII International AIDS conference (AIDS 2010) in Vienna makes the case for a new model for scaling up treatment and prevention of HIV amongst Injecting Drug Users (IDUs).
Jul 22, 2010 - 4:00:00 AM
|
Latest Research
Mother-to-child HIV transmission rate falling, but more can be done
Transmission of HIV to children before or at birth has dropped dramatically around the country in the last decade since the advent of powerful new therapies. That certainly is true for Florida, where each year, fewer than 10 babies are born with the disease despite the fact that more than 600 HIV-positive women each year, on average, give birth.
Jul 22, 2010 - 4:00:00 AM
|
Latest Research
$9M NIH grant renewal awarded to Case Western Reserve/UHCMC Center for AIDS Research
The Case Western Reserve University/University Hospitals Case Medical Center Center for AIDS Research (CFAR) announced today it has received a five-year renewal grant from the National Institutes of Health (NIH) for $9 million. The CFAR provides clinical and technological support to researchers working on HIV-related projects at Case Western Reserve, University Hospital Case Medical Center, MetroHealth Medical Center, Cleveland Clinic, and several international sites.
Jul 21, 2010 - 4:00:00 AM
|
Latest Research
HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study
The BC Centre of Excellence in HIV/AIDS (BC-CfE) published an important study today in the globally respected Lancet medical journal. The study strongly reinforces the view that the benefits of highly active antiretroviral therapy (HAART) extend beyond treatment of the virus to significantly preventing the transmission and spread of HIV.
Jul 19, 2010 - 4:00:00 AM
|
Latest Research
Retrovirus replication process different than thought
How a retrovirus, like HIV, reproduces and assembles new viruses is different than previously thought, according to Penn State College of Medicine researchers. Understanding the steps a virus takes for assembly could allow development of a way to prevent the spread of retroviral diseases.
Jul 15, 2010 - 4:00:00 AM
|
Latest Research
Faith-based groups can aid response to HIV in Central America, study finds
Faith-based organizations such as churches and religious relief and development groups can play an important role in the response to HIV and AIDS in Central America, according to a new RAND Corporation report.
Jun 1, 2010 - 4:00:00 AM
|
Latest Research
Rare hybrid cell key to regulating the immune system
Toni BakerPublic Relations ManagerMedical College of Georgia706-721-4421 Office 706-732-0401 Beeper706-825-6473 Cell tbaker@mcg.edu
May 24, 2010 - 4:00:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Dynamic detection technique for HIV
A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.
May 19, 2010 - 2:35:40 PM
|
Latest Research
HHS Secretary Sebelius announces $1 billion in NIH Recovery Act awards for research construction
U.S. Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.
May 14, 2010 - 4:00:00 AM
|
Latest Research
Researchers share insights into RNA
LA JOLLA, Calif., May 11, 2010 -- Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.
May 11, 2010 - 4:00:00 AM
|
Latest Research
LA BioMed to receive $9.7 million stimulus grant for new research center
LOS ANGELES (April 8, 2010) With a goal of creating jobs and enhancing chronic disease studies, the federal government is awarding a $9.7 million grant of stimulus funds to the Los Angeles Biomedical Research Institute (LA BioMed) for the construction of a new Chronic Disease Clinical Research Center on its campus, David I. Meyer, PhD, the institute's president and CEO, announced today.
Apr 8, 2010 - 4:00:00 AM
|
Latest Research
Think again about keeping little ones so squeaky clean
EVANSTON, Ill. --- A new Northwestern University study suggests that American parents should ease up on antibacterial soap and perhaps allow their little ones a romp or two in the mud --- or at least a much better acquaintance with everyday germs.
Dec 8, 2009 - 5:00:00 AM
|
Latest Research
HIV-related memory loss linked to Alzheimer's protein
More than half of HIV patients experience memory problems and other cognitive impairments as they age, and doctors know little about the underlying causes. New research from Washington University School of Medicine in St. Louis suggests HIV-related cognitive deficits share a common link with Alzheimer's-related dementia: low levels of the protein amyloid beta in the spinal fluid.
Dec 7, 2009 - 5:00:00 AM
|
Latest Research
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Nov 12, 2009 - 5:00:00 AM
|
Latest Research
Indiana U. at APHA: Studies about why men and women use lubricants during sex
An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.
Nov 9, 2009 - 5:00:00 AM
|
Latest Research
Federal stimulus funds support studies geared to improving HIV care and prevention
UCSF HIV researchers have received two NIH grants of $1 million each to study the use of web-based, patient controlled personal health records to improve health and HIV prevention outcomes for HIV positive patients.
Nov 5, 2009 - 5:00:00 AM
|
Latest Research
Specialists in hearing, HIV come together to study AIDS patients
Specialists in HIV and in hearing at the University of Rochester Medical Center are teaming up to measure the hearing of people with AIDS.
Nov 3, 2009 - 5:00:00 AM
|
Latest Research
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both part of the National Institutes of Health.
Oct 9, 2009 - 4:00:00 AM
|
Latest Research
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
Sep 24, 2009 - 4:00:00 AM
|
Latest Research
Clinical trial of antiretroviral-based HIV prevention strategies for women now under way
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.
Sep 16, 2009 - 4:00:00 AM
|
Latest Research
ART therapy for babies, mothers safely reduces HIV transmission
Giving daily antiretroviral syrup to breastfeeding infants or treating their HIV-infected mothers with highly active antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a study led by University of North Carolina at Chapel Hill investigators has found.
Jul 22, 2009 - 4:00:00 AM
|
Latest Research
New method for HIV testing holds promise for developing world
DURHAM, NC -- A new technique that detects the HIV virus early and monitors its development without requiring refrigeration may make AIDS testing more accessible in sub-Saharan Africa.
Jul 21, 2009 - 4:00:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Treatment with highly active antiretroviral therapy for HIV helps control Hepatitis B
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study by researchers at Wake Forest University School of Medicine.
Jul 15, 2009 - 2:12:37 PM
|
Latest Research
Probiotics can increase effectiveness of some antibiotic therapies
Antimicrobial treatments for bacterial vaginosis (BV) are effective, but taking lactobacillus tablets alongside metronidazole antibiotic therapy increases effectiveness over taking this antibiotic alone, according to a Cochrane Systematic Review. The researchers also concluded that intravaginal lactobacillus was as effective as oral metronidazole, although they did note unexplained drop-outs from the trials.
Jul 9, 2009 - 4:00:00 AM
|
Medical News
:
Professionals
:
Doctors
Indian American helps design vaginal ring to prevent HIV transmission
An Indian American endocrinologist has helped develop a vaginal ring that would prevent conception and transmission of HIV infection, by releasing multiple types of non-hormonal agents and microbicides.
Jun 18, 2009 - 12:27:59 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
One step closer to the HIV vaccine
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
May 17, 2009 - 11:05:52 AM
|
Latest Research
Humanized mouse infected with HIV vaginally and rectally allows testing
The humanized mouse developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection. The virus only infects humans and chimpanzees, which are protected as endangered species.
Apr 19, 2009 - 4:00:00 AM
|
Latest Research
Education slowing AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.
Mar 22, 2009 - 4:00:00 AM
|
Latest Research
UCSF Transgender HIV Prevention Center funded to provide primary care information
The UCSF Center of Excellence for Transgender HIV Prevention (CoE) has received a grant from The California Endowment that will expand access to information and resources on providing culturally competent health care to trangender individuals.
Mar 12, 2009 - 4:00:00 AM
|
Latest Research
Clinical trial finds microbicide promising as HIV prevention method for women
March 5, 2009 -- A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. According to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI), one 0.5 % dose of a microbicide designed to prevent HIV from attaching to cells in the genital tract, was 30% effective. While the results are encouraging, researchers on the study, known as HPTN 035, report that additional evidence is needed to determine more definitively its effectiveness.
Mar 5, 2009 - 5:00:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
High rate of HIV treatment interruption among newly released prison inmates
Approximately 80 percent of HIV-infected Texas prison inmates did not fill an initial prescription for antiretroviral therapy within 30 days of their release from prison, potentially increasing their risk for harmful health consequences because of an interruption of treatment, according to a study in the February 25 issue of JAMA.
Feb 25, 2009 - 12:38:29 AM
|
Latest Research
Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
NorTech, in partnership with Crain's Cleveland Business, today presented a 2009 NorTech Innovation Award to Eric J. Arts, Ph.D., for his development of a Biotech Platform to Detect, Monitor, and Treat Viral Diseases. Dr. Arts and his research team developed a set of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease strength of the virus. The technology can also be used in academic research to better understand HIV/AIDS and to develop vaccines. Dr. Arts is an Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve University School of Medicine. He is also Director of the Uganda Laboratory Core for the Case Western Reserve University Center for Aids Research.
Feb 23, 2009 - 5:00:00 AM
|
Latest Research
UCSF symposium considers biomedical approaches to HIV/AIDS prevention
New and emerging biomedical approaches to HIV/AIDS prevention will be the focus of a daylong symposium on February 24 sponsored by the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research (CFAR) and the UCSF Center for AIDS Prevention Studies.
Feb 12, 2009 - 5:00:00 AM
|
Latest Research
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
WHAT: For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. One potential prevention strategy involves giving antiretroviral drug regimens to people who are at high risk for HIV to protect them from infection. Important questions about this experimental approach, known as pre-exposure prophylaxis (PrEP), remain unanswered, including, Could PrEP cut the lifetime risk of HIV infection? Would PrEP be cost-effective?
Feb 9, 2009 - 5:00:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Breast fed babies on Nevirapine prophylaxis are at risk of developing drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report.
Jan 5, 2009 - 11:50:50 AM
|
|
|
|
|
| Health |
Best way to boost adult immunizations is through office-based action, study finds
|
'Pep talk' can revive immune cells exhausted by chronic viral infection
|
Burning more sugar drives super athleticism
|
Research aims to prevent obesity by reaching parents, young children through child care
|
AMD-like lesions delayed in mice fed lower glycemic index diet
|
Low vitamin C levels may raise heart failure patients' risk
|
Sugar-sweetened beverages may increase cardiovascular risk in women
|
Study finds shifting disease burden following universal Hib vaccination
|
UT study: Climate change affects ants and biodiversity
|
Dirt prevents allergy
|
| | Healthcare |
Fitness club memberships help insurance plans to enrol healthier patients
|
Anxiety disorders mount since credit crunch
|
Doctors diagnose patients within moments of meeting
|
Physician-defined patient complexity differs from current diagnosis-based measures
|
Free health screening for school children Nov 14
|
Systematic bias in the assessment of UK doctors
|
White children far more likely to receive CT scans than Hispanic, African-American children
|
Suspected brain disease kills 51 kids in Bihar
|
New rules for bio-medical waste management in India
|
Delhi hospitals lacking in emergency protocols
|
| | Latest Research |
New device performs better than old for removing blood clots
|
Gene related to fat preferences in humans found
|
Cardiovascular Nursing Spring Meeting
|
The effect of occasional binge drinking on heart disease and mortality among moderate drinkers
|
ORNL, partners earn FLC honor for cookstove technology
|
Clot-busting drugs appear safe for treating 'wake-up' stroke patients
|
Infections in childhood linked to high risk of ischemic stroke
|
Penn State scientists elected to American Geophysical Union
|
Wayne State University project aims to reduce HIV, AIDS among African-Americans
|
Scientists help define structure of exoplanets
|
| | Medical News |
Women delivers baby near lift in Noida hospital
|
Obesity on rise in school children: Study
|
Over 10,000 dengue cases in India this year
|
NRI doctors demands removal of 'tainted' medical council members
|
Watch out for sexually transmitted 'superbug': Expert
|
Panel stresses on infection control in hospitals
|
Healthcare cost up 22 times in rural areas, shows study
|
Superbug exists, but nothing alarming: Walia
|
No power problem at AIIMS: Official
|
40 percent Indians embarrassed to ask for contraceptives
|
| | Special Topics |
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
|
|
